Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020 Report; 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed August 25, 2021.
   Google Scholar
• Blasi F, Cesana G, Conti S, et al. The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. PLoS One. 2014;9(6):e101228. doi:10.1371/journal.pone.0101228
   PubMed Web of Science ®Google Scholar
• Dalal AA, Shah M, D’Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med. 2011;105(3):454–460. doi:10.1016/j.rmed.2010.09.003
   PubMed Web of Science ®Google Scholar
• Guerra B, Gaveikaite V, Bianchi C, Puhan MA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):160061. doi:10.1183/16000617.0061-2016
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Feenstra TL, Boland M, et al. Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. Int J Chron Obstruct Pulmon Dis. 2017;12:3183–3194. doi:10.2147/COPD.S142378
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Ställberg B, Lisspers K, Larsson K, et al. Predicting hospitalization due to COPD exacerbations in Swedish primary care patients using machine learning – based on the ARCTIC study. Int J Chron Obstruct Pulmon Dis. 2021;16:677–688. doi:10.2147/COPD.S293099
   PubMed Web of Science ®Google Scholar
• Ställberg B, Janson C, Larsson K, et al. Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients. NPJ Prim Care Respir Med. 2018;28(1):33. doi:10.1038/s41533-018-0101-y
   PubMed Web of Science ®Google Scholar
• Kaszuba E, Odeberg H, Rastam L, Halling A. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study. BMC Fam Pract. 2018;19(1):178. doi:10.1186/s12875-018-0865-8
   PubMed Web of Science ®Google Scholar
• Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017;18(1):31. doi:10.1186/s12931-017-0512-2
   PubMed Web of Science ®Google Scholar
• Tavakoli H, Chen W, Sin DD, FitzGerald JM, Sadatsafavi M. Predicting severe chronic obstructive pulmonary disease exacerbations. Developing a population surveillance approach with administrative data. Ann Am Thorac Soc. 2020;17(9):1069–1076. doi:10.1513/AnnalsATS.202001-070OC
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhu J, Liu Y, et al. Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis. BMJ. 2018;363:k4388. doi:10.1136/bmj.k4388
   PubMed Web of Science ®Google Scholar
• Bogart M, Glassberg MB, Reinsch T, Stanford RH. Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting. Respir Med. 2018;145:138–144. doi:10.1016/j.rmed.2018.10.013
   PubMed Web of Science ®Google Scholar
• Yu AP, Guérin A, Ponce de Leon D, et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers. J Med Econ. 2011;14(4):486–496. doi:10.3111/13696998.2011.594123
   PubMedGoogle Scholar
• Bogart M, Wu B, Germain G, et al. Real-world adherence to single-inhaler vs multiple-inhaler triple therapy among patients with COPD in a commercially insured US population. Chest. 2020;158(4):Supplement A1773–A1774. doi:10.1016/j.chest.2020.08.1548
   Web of Science ®Google Scholar
• Xing H, McDonagh PD, Bienkowska J, et al. Causal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritis. PLoS Comput Biol. 2011;7(3):e1001105. doi:10.1371/journal.pcbi.1001105
   PubMed Web of Science ®Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Brill SE, Wedzicha JA. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:1241–1252. doi:10.2147/COPD.S41476
   PubMed Web of Science ®Google Scholar
• Ma Y, Tong H, Zhang X, et al. Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis. Respir Res. 2019;20(1):144. doi:10.1186/s12931-019-1123-x
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Bendstrup E, Pedersen AB, et al. Increased mortality among patients with rheumatoid arthritis and COPD: a population-based study. Respir Med. 2018;140:101–107. doi:10.1016/j.rmed.2018.06.010
   PubMed Web of Science ®Google Scholar
• Mcguire K, Aviña-Zubieta JA, Esdaile JM, et al. Risk of incident chronic obstructive pulmonary disease in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2019;71(5):602–610. doi:10.1002/acr.23410
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest. 2010;137(2):326–332. doi:10.1378/chest.09-0482
   PubMed Web of Science ®Google Scholar
• Falk JA, Minai OA, Mosenifar Z. Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):506–512. doi:10.1513/pats.200707-096ET
   PubMedGoogle Scholar
• McMahon TJ, Prybylowski AC. Anemia in the patient with chronic lung disease. In: Provenzano R, Lerma E, Szczech L, (editors). Management of Anemia. New York: Springer; 2018:143–155. doi.10.1007/978-1-4939-7360-6_8.
   Google Scholar
• Latourelle JC, Beste MT, Hadzi TC, et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson’s disease: a longitudinal cohort study and validation. Lancet Neurol. 2017;16(11):908–916. doi:10.1016/S1474-4422(17)30328-9
   PubMed Web of Science ®Google Scholar
• Berger JS, Haskell L, Ting W, et al. Machine learning methodology predicts comorbidities are associated with increased total healthcare costs among patients with severe peripheral artery disease. Poster presented at: The American Heart Association Quality of Care and Outcomes Research Scientific Sessions; April 2–3, 2017, Arlington, Virginia. Circulation: Cardiovascular Quality and Outcomes. 2017;10(Suppl_3):A150. doi:10.1161/circoutcomes.10.suppl_3.150
   Google Scholar
• Ivanov V, Torgovitsky R, Tchetgen ET, et al. Using clinical trial and real world data to bridge efficacy to effectiveness of fingolimod in multiple sclerosis patients. Value Health. 2016;19(7):PA426. doi:10.1016/j.jval.2016.09.461
   Web of Science ®Google Scholar
• Anderson JP, Parikh JR, Shenfeld DK, et al. Reverse engineering and evaluation of prediction models for progression to type 2 diabetes: an application of machine learning using electronic health records. J Diabetes Sci Technol. 2016;10(1):6–18. doi:10.1177/1932296815620200
   Google Scholar